Clinical and genomic landscape of RAS pathway mutations in gynecologic cancers.

Authors

null

Ji Son

University of Texas MD Anderson Cancer Center, Houston, TX

Ji Son , Yingao Zhang , Mirella Nardo , Oriol Mirallas , Robert Tyler Hillman , Heather Y. Lin , Erick Campbell , Vijaykumar Holla , Amber Johnson , Natalie Clark , Pablo Alvarez-Ballesteros , Ying Yuan , Lauren Patterson Cobb , David Marc Gershenson , Amir A. Jazaeri , Pamela T. Soliman , Shannon Neville Westin , Funda Meric-Bernstam , David S. Hong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Other Gynecologic Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5611)

DOI

10.1200/JCO.2023.41.16_suppl.5611

Abstract #

5611

Poster Bd #

306

Abstract Disclosures

Similar Posters

Poster

2014 Gastrointestinal Cancers Symposium

Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).

Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).

First Author: Rachna T. Shroff

Poster

2016 ASCO Annual Meeting

Comprehensive Genomic sequencing (CGS) of 90 patient samples of anaplastic thyroid cancer (ATC).

Comprehensive Genomic sequencing (CGS) of 90 patient samples of anaplastic thyroid cancer (ATC).

First Author: Saad A. Khan

Poster

2014 ASCO Annual Meeting

Advanced or recurrent endometrial cancer (EC) and co-occurring mutations in multiple oncogenic pathways.

Advanced or recurrent endometrial cancer (EC) and co-occurring mutations in multiple oncogenic pathways.

First Author: Alexandra Leary

Poster

2024 ASCO Gastrointestinal Cancers Symposium

<span>Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).</span>

Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).

First Author: Patrick M Boland